We are live on ! Find out more
PC

Paulson & Co Portfolio holdings

AUM $2.58B
1-Year Est. Return 68.51%
This Fund
S&P 500
This Quarter Est. Return
-3.23%
1 Year Est. Return
+68.51%
3 Year Est. Return
+251.48%
5 Year Est. Return
+229.81%
10 Year Est. Return
+881.28%
AUM
$5.57B
AUM Growth
-$1.83B
Cap. Flow
-$1.38B
Cap. Flow %
-24.83%
Top 10 Hldgs %
64.19%
Holding
115
New
6
Increased
5
Reduced
20
Closed
62

Top Buys

Rank Stock Value
1
AABA
Altaba Inc
AABA
+$69M
2
DISH
DISH Network Corp.
DISH
+$40.1M
3
CPN
Calpine Corporation
CPN
+$24M
4
S
Sprint Corporation
S
+$19.5M
5
EQT icon
EQT Corp
EQT
+$18.3M

Top Sells

Rank Stock Value
1
AIG icon
American International
AIG
+$259M
2
NXPI icon
NXP Semiconductors
NXPI
+$133M
3
AGN
Allergan plc
AGN
+$122M
4
HOUS
Anywhere Real Estate
HOUS
+$101M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$96.6M

Sector Composition

Rank Sector Weight
1 Healthcare 41.18%
2 Communication Services 17.11%
3 Miscellaneous 11.91%
4 Consumer Discretionary 10.12%
5 Materials 7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LOXO
51
DELISTED
Loxo Oncology, Inc
LOXO
$2.1M 0.04%
22,800
-664,093
-97% -$51.6M
NXPI icon
52
NXP Semiconductors
NXPI
$59.7B
$1.41M 0.03%
12,500
-1,188,164
-99% -$133M
HUN icon
53
Huntsman Corp
HUN
$1.67B
$137K ﹤0.01%
5,000
-8,000
-62% -$213K
AAPL icon
54
Apple
AAPL
$4.86T
– –
-49,200
Closed -$1.77M
AIG icon
55
American International
AIG
$39.4B
– –
-4,140,763
Closed -$259M
AMZN icon
56
Amazon
AMZN
$2.73T
– –
-156,000
Closed -$7.55M
BCRX icon
57
BioCryst Pharmaceuticals
BCRX
$2.1B
– –
-349,500
Closed -$1.94M
BPMC
58
DELISTED
Blueprint Medicines
BPMC
– –
-65,800
Closed -$3.33M
CRSP icon
59
CRISPR Therapeutics
CRSP
$5.12B
– –
-28,500
Closed -$457K
CYH icon
60
PUT
Community Health Systems
CYH
$412M
– –
-340,000
Closed -$3.39M
DVAX
61
DELISTED
Dynavax Technologies
DVAX
– –
-554,600
Closed -$5.35M
DXCM icon
62
DexCom
DXCM
$31.3B
– –
-733,600
Closed -$13.4M
EDIT icon
63
Editas Medicine
EDIT
$415M
– –
-50,000
Closed -$839K
ESPR
64
DELISTED
Esperion Therapeutics
ESPR
– –
-210,500
Closed -$9.74M
FDX icon
65
FedEx
FDX
$74B
– –
-75,400
Closed -$16.4M
GOOG icon
66
Alphabet (Google) Class C
GOOG
$4.23T
– –
-80,000
Closed -$3.63M
GRFS
67
Grifois
GRFS
$5.14B
– –
-196,753
Closed -$4.16M
GSK icon
68
GSK
GSK
$100B
– –
-231,600
Closed -$12.5M
HALO icon
69
Halozyme
HALO
$12.2B
– –
-111,100
Closed -$1.42M
HCA icon
70
HCA Healthcare
HCA
$92.4B
– –
-90,000
Closed -$7.85M
HWM icon
71
Howmet Aerospace
HWM
$90.6B
– –
-1,170,340
Closed -$20.3M
ISRG icon
72
Intuitive Surgical
ISRG
$134B
– –
-91,800
Closed -$9.54M
MELI icon
73
Mercado Libre
MELI
$96.3B
– –
-20,000
Closed -$5.02M
META icon
74
Meta Platforms (Facebook)
META
$1.7T
– –
-144,500
Closed -$21.8M
NTLA icon
75
Intellia Therapeutics
NTLA
$1.66B
– –
-48,600
Closed -$778K
1 2
3
4 5

Similar funds

TC
Trilogy Capital Irvine, California $2.58B AUM 22.97% 1-Year Est. Return
RFP
Root Financial Partners Encinitas, California $2.57B AUM 21.7% 1-Year Est. Return
EV
Eclipse Ventures Palo Alto, California $2.57B AUM
MC
Moors & Cabot Boston, Massachusetts $2.57B AUM 37.84% 1-Year Est. Return
PI
PFG Investments Woodbury, New York $2.58B AUM 36.93% 1-Year Est. Return
CL
CSS LLC Chicago, Illinois $2.57B AUM 67.1% 1-Year Est. Return
CTA
Chesley Taft & Associates Chicago, Illinois $2.57B AUM 22.93% 1-Year Est. Return
VWM
Venturi Wealth Management Austin, Texas $2.58B AUM 41.25% 1-Year Est. Return

Paulson & Co's Q3 2017 Portfolio in Review

As of Q3 2017, Paulson & Co held 115 positions worth $5.57B, down 25% from $7.4B the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Paulson & Co withdrew a net $1.38B in Q3 2017, closing 62 positions and reducing 20 holdings. Its most notable exit was American International, an estimated $259M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, down from 45% a quarter earlier, followed by Communication Services and Miscellaneous.

Against the trend, Paulson & Co opened a new position in Calpine Corporation worth $24.8M.

  • Paulson & Co's largest Q3 2017 buy was Calpine Corporation: 1,683,200 shares worth $24.8M.
  • Paulson & Co added most to Altaba Inc in Q3 2017, an estimated $69M increase.
  • Paulson & Co's biggest Q3 2017 reduction was NXP Semiconductors, cutting an estimated $133M.
  • Paulson & Co fully exited American International in Q3 2017, selling an estimated $259M.
  • Paulson & Co's ten largest holdings make up 64% of its $5.57B portfolio in Q3 2017.
  • Paulson & Co opened 6 new positions and closed 62 in Q3 2017.
  • Paulson & Co's portfolio value fell 25% quarter-over-quarter to $5.57B.

Based on Paulson & Co's 13F filing for Q3 2017, filed 14 Nov 2017.